TPST-1495

TPST-1495 · Tempest Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TPST-1495, covering 2025-09-12 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis [Phase 2]